Analysts predict a revenue drop and higher losses per share ...
Analysts predict a revenue drop and higher losses per share for Amylyx Pharmaceuticals, indicating slower sales growth than the market, potentially causing market wariness.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002723053b6dcfa7.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment